Evidence map›Paper›PMID 37598155›Full record

ArticleJournal of nanobiotechnology2023

Photosensitizing deep-seated cancer cells with photoprotein-conjugated upconversion nanoparticles.

Sung Hyun Park, Soohyun Han, Sangwoo Park, Hyung Shik Kim, Kyung-Min Kim, Suyeon Kim, Dong Yun Lee, Joonseok Lee, Young-Pil Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sung Hyun Park *Department of HY-KIST Bio-Convergence, Hanyang University, Seoul, 04763, Republic of Korea.
Soohyun Han *Department of HY-KIST Bio-Convergence, Hanyang University, Seoul, 04763, Republic of Korea.
Sangwoo Park *Department of Life Science, Hanyang University, Seoul, 04763, Republic of Korea.
Hyung Shik KimDepartment of Bioengineering, College of Engineering, BK FOUR Biopharmaceutical Innovation Leader for Education and Research Group, Hanyang University, Seoul, 04763, Republic of Korea.
Kyung-Min KimDepartment of Life Science, Hanyang University, Seoul, 04763, Republic of Korea.
Suyeon KimDepartment of Chemistry, Hanyang University, Seoul, 04763, Republic of Korea.
Dong Yun LeeDepartment of Bioengineering, College of Engineering, BK FOUR Biopharmaceutical Innovation Leader for Education and Research Group, Hanyang University, Seoul, 04763, Republic of Korea. dongyunlee@hanyang.ac.kr.
Joonseok LeeResearch Institute for Convergence of Basic Science, Hanyang University, Seoul, 04763, Republic of Korea. joonseoklee@hanayng.ac.kr.
Young-Pil KimDepartment of HY-KIST Bio-Convergence, Hanyang University, Seoul, 04763, Republic of Korea. ypilkim@hanyang.ac.kr.
Hanyang University · KR

Funding

Korea Institute of Science and Technology 2Z06270-20-137National Research Foundation of Korea 2020R1A2C2101111 and 2021M3E5E3080381National Research Foundation of Korea 2021R1C1C2011181National Research Foundation of Korea 2022R1A2B5B02002324National Research Foundation of Korea 2022R1A4A1030421
6 · The paper itself

Abstract

To resolve the problem of target specificity and light transmission to deep-seated tissues in photodynamic therapy (PDT), we report a cancer cell-targeted photosensitizer using photoprotein-conjugated upconversion nanoparticles (UCNPs) with high target specificity and efficient light transmission to deep tissues. Core-shell UCNPs with low internal energy back transfer were conjugated with recombinant proteins that consists of a photosensitizer (KillerRed; KR) and a cancer cell-targeted lead peptide (LP). Under near infrared (NIR)-irradiating condition, the UCNP-KR-LP generated superoxide anion radicals as reactive oxygen species via NIR-to-green light conversion and exhibited excellent specificity to target cancer cells through receptor-mediated cell adhesion. Consequently, this photosensitizing process facilitated rapid cell death in cancer cell lines (MCF-7, MDA-MB-231, and U-87MG) overexpressing integrin beta 1 (ITGB1) receptors but not in a cell line (SK-BR-3) with reduced ITGB1 expression and a non-invasive normal breast cell line (MCF-10A). In contrast to green light irradiation, NIR light irradiation exhibited significant PDT efficacy in cancer cells located beneath porcine skin tissues up to a depth of 10 mm, as well as in vivo tumor xenograft mouse models. This finding suggests that the designed nanocomposite is useful for sensing and targeting various deep-seated tumors.

Indexed as

NanoparticlesNeoplasmsAnimalsBreastHumansLightLuminescent ProteinsMicePhotosensitizing AgentsSwineLuminescent ProteinsPhotosensitizing AgentsNear-infrared lightPhotodynamic therapyProtein photosensitizersReactive oxygen speciesUpconversion nanoparticles

Identifiers

PMID37598155
PMCPMC10439569
OpenAlexW4386000776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.